Global pharma deal value rises to $18.3 billion in July 2025: GlobalData
Merck, Nordic Capital, and Sanofi drive 79 per cent of July’s total deal value as venture capital activity records a decline
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Medistep Healthcare eyes ₹16.09 cr fundraise to acquire new plant & machinery
A significant portion of the IPO proceeds will be allocated toward the acquisition and installation of advanced equipment at the…
Startups: India’s next big bet on pharma innovation?
While India’s pharma startups can resolve scientific and systemic blind spots, funding remains the missing link blocking scalable…
India’s pharma funding reaches $294 million in July 2025
Pharma funding snapshot highlights late-stage dominance and surge in capital flow, with Meril’s $200M round leading July’s…
US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
The imposition of tariffs threatens to elevate costs, creating uncertainty in launch planning, particularly for late-stage assets…
China’s obesity market forecasts rise with homegrown therapies and late-stage pipeline
With ten other drugs in Phase III development by domestic companies, according to GlobalData’s Pharmaceutical Intelligence Center,…
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
PharmNXT acquires DTR, brings European bioprocess engineering to India
This move enables PharmNXT to access technology solutions related to single-use systems
Pfizer completes licensing agreement with 3SBio
The agreement allows Pfizer to manufacture and commercialise 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF…
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share
The issue is expected to raise ₹4,992.51 lakh, which will be utilised to strengthen the company’s balance sheet, support growth…
NATCO Pharma offers to acquire stake in South African Adcock Ingram Holdings
Adcock Ingram generated revenue of R9.6 billion ($ 536 million*) in the financial year June’24 and delivered a gross margin of…
Akums launches high-strength Paracetamol Oral Suspension 500mg/5ml
This novel oral suspension is an addition to the analgesic and antipyretic category by offering therapeutic adult dosing in a…
Cipla invests in iCaltech Innovations to strengthen respiratory play
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core…
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape
According to GlobalData, the 2024 approvals included significant milestones in the biosimilar sector, with the FDA granting…
Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital
Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…
Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData
Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…
Pulmonary arterial hypertension market to reach $9.3 bn in 7MM by 2034
GlobalData’s latest report reveals that the US market is the largest PAH market in the 7MM, accounting for 76.3 per cent of global…
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData
According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…